Stay updated on Oral Decitabine Combo with Magrolimab in MDS Clinical Trial

Sign up to get notified when there's something new on the Oral Decitabine Combo with Magrolimab in MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Oral Decitabine Combo with Magrolimab in MDS Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    14 days ago
    Change Detected
    Summary
    The value 03 has recently changed to 06 on the webpage, indicating a modification in the Last Update Posted date of a study related to the termination of magrolimab development in MDS, a medical condition.
    Difference
    0.3%
    Check dated 2024-05-07T15:26:45.000Z thumbnail image
  7. Check
    17 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 2023-09-06 to 2024-05-03, indicating an update in the study details related to a Study of Oral Decitabine/Cedazuridine in Combination With Magrolimab for participants with Intermediate- to Very High-Risk Myelodysplastic Syndromes (MDS). This change may be significant for individuals monitoring medical and healthcare-related publications and documentation.
    Difference
    1.0%
    Check dated 2024-05-04T09:37:22.000Z thumbnail image
  8. Check
    21 days ago
    Change Detected
    Difference
    3%
    Check dated 2024-04-30T22:16:02.000Z thumbnail image

Stay in the know with updates to Oral Decitabine Combo with Magrolimab in MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Oral Decitabine Combo with Magrolimab in MDS Clinical Trial page.